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1. Introduction 
Human papillomavirus (HPV) infection is recognized today as the main causal factor for 
~100% of cervical cancer cases in the world and of a substantial proportion of many other 
anogenital neoplasms (anal, vaginal, vulvar, and penile cancer). HPV is also implicated in 
the genesis of several other cancers, such as head and neck (oral cavity, pharynx, and 
larynx) cancer and non-melanoma skin cancer and is suspected also to play a causal role in 
the genesis of a few other neoplasms (Trottier et al, 2009). The epidemiology of mucosal 
human papillomavirus (HPV) as been well studied today, especially cervicovaginal HPV 
infection among young women and there are also more available epidemiologic data for 
older women, men and as well as for children. HPV infection is the most common sexually 
transmitted infections in the world. The predominant route of transmission is via sexual 
contact, although vertical and horizontal transmissions also occur. This chapter will review 
the epidemiology of mucosal HPV infections affecting genital, oral and conjunctival mucosa 
in adults and children. This chapter will detail the epidemiology of HPV in adult 
considering young versus older population rather than focussing on adolescent and adult 
populations separately because there is no universal cut-off age group to define high risk 
population as HPV is highly dependant on the onset of sexual activity.  
2. Classification and carcinogenicity of HPVs  
More than 100 HPV genotypes have been catalogued so far and can be classified according 
to the phylogenetics in genera and species (De Villiers et al, 2004) (table 1).  The L1 protein is 
highly conserved among all HPV genotypes and is thus used for taxonomical purposes. 
Different genera of the Papillomaviridae (Alpha, Beta, etc.) share less than 60% nucleotide 
sequence identity in the L1 protein whereas species within a genus share between 60% and 
70% nucleotide identity. A new HPV isolate is recognized as a new genotype when the 
nucleotide sequence of the L1 gene differs by more than 10% from the genotype with which 
it has greatest homology in DNA sequence.  
Papillomaviruses can also be classified according to their tissue tropism (mucosal or 
cutaneous) and oncogenic potential (table 2) (De Villiers et al, 2004). Although it is possible  
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Genus Species Genotypes of HPV 
Alpha-papillomavirus 
Alpha-1 42 
Alpha-2 3, 10, 28,29, 77, 78, 94 
Alpha-3 61, c62, 72, 81, 83, c87, c86, c89, 84, 
Alpha-4 2, 27, 57 
Alpha-5 26, 51, 69, 82 
Alpha-6 30, 53, 56, 66 
Alpha-7 18, 45, 59, c85, 39, 68, 70 
Alpha-8 7, 40, 43, c91 
Alpha-9 16, 31, 33, 35, 52, 58, 67 
Alpha-10 6, 11, 13, 44, 55, 74 
Alpha-11 34, 73 
Alpha-12 RhPV1 
Alpha-13 54 
Alpha-14 c90 
Alpha-15 71 
Beta-papillomavirus 
Beta-1 5, 8, 12, 14, 19, 20, 21, 24, 25, 36, 47, 93 
Beta-2 9, 15, 17, 22, 23, 37, 80, 
Beta-3 38, 49, 75, 76 
Beta-4 92 
Beta-5 96 
Gamma-papillomavirus 
Gamma-1 4, 65, 95 
Gamma-2 50 
Gamma-3 48 
Gamma-4 60 
Gamma-5 88 
Mu-papillomavirus Mu-1 1 
 Mu-2 63 
Nu-papillomavirus Nu 41 
Adapted from De Villiers et al, 2004. 
Table 1.  Phylogenetics of Papillomaviridae affecting humans 
to find all these genotypes in both mucosal and cutaneous tissue, they are classified 
according to their tissue tropism as shown in table 2. This chapter will focus on the 
genotypes of HPV that infect the epithelial lining of the anogenital tract and other mucosal 
areas of the body (mucosal HPV). There are over than 40 genotypes of HPV that infect 
human mucosal from which 13–25 genotypes have been identified as probable or definite 
high-oncogenic risk (HR-HPV) according to their frequency of association with cervical 
cancer and other anogenital cancers (review in Trottier et al, 2006; IARC 2007; IARC 2011). 
Although, the vast majority of infected people will clear mucosal HPV infections without 
any clinical consequences, its role in the pathogenesis of malignant tumours has been well 
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described. HR-HPV is recognized unequivocally as the main causal factor for (~100%) 
cervical cancer, is responsible for a substantial proportion of many other (60-90 %) 
anogenital neoplasms (anal, vaginal, vulvar and penile cancers), and a non negligible 
portion (~30%) of head and neck cancers (oral cavity, pharynx, and larynx), and is suspected 
to play a causal role in many other neoplasms, such as conjunctiva carcinoma and lung 
cancer (Trottier et al, 2009). The latest classification published by the World Health 
Organization’s International Agency for Research on Cancer (IARC) referred HPV-16, 18, 31, 
33, 35, 39, 45, 51, 52, 56, 58, 59 as HR-HPVs (IARC, 2011). This classification included also 
many other genotypes as probably carcinogenic such as HPV genotypes 26, 30, 34, 53, 66, 67, 
68, 69, 70, 73, 82, 85, 97.  Infection with low-oncogenic risk HPVs (LR-HPV), such as HPV-6 
and 11, can cause benign lesions of the anogenital areas known as Condylomata acuminate 
(genital warts), a large proportion of low-grade squamous intraepithelial lesions (LSIL) of 
the cervix, oral papillomas as well as conjunctival papillomas.  HPV-6 or 11 may also cause 
in rare instance recurrent respiratory papillomatosis, which in infants and young children 
can be very morbid and usually perinatally transmitted (Armstrong et al. 2000) whereas in 
adult it is usually sexually transmitted and less severe than in children (Kashima et al, 1992). 
 
Tissue tropism Genotypes of HPV 
 
Mucosal High-risk: 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59 
Low-risk (or probably carcinogenic): 6, 11, 13, 26, 30, 32, 34, 42, 44, 53, 
54, 61, 62, 66, 67, 68, 69, 70, 71, 72, 73, 74, 81, 82, 83, 84, 85, 86, 87, 89, 90 
Cutaneous 1, 2, 4, 5, 8, 9, 12 ,1 4, 15 ,17, 19, 20, 21, 22, 23,  25, 27, 36, 37, 38, 41, 47, 
48, 49, 50, 57, 60, 63, 65, 75, 76, 80, 88, 92, 93, 95, 96 
Both (mixte) 3, 7, 10, 28, 29, 40, 43, 78, 91, 94 
Adapted from De Villiers et al, 2004. Carcinogenic potential classification based on IARC monograph, 
Vol 100B, 2009. 
Table 2. Classifications of HPVs according to their tissue tropism and oncogenic potential 
3. Mode of transmission of mucosal HPV 
3.1 Predominant route of transmission is via sexual contact 
There is a strong and consistent association between sexual activity and mucosal HPV 
infections (Winer et al 2008). The number of lifetime and recent partners is one of the 
strongest risk factors for prevalent infection as well as acquisition in adult (Trottier et al, 
2006).  Further data supporting sexual intercourse as the primary route of genital HPV 
infection include documented transmission of genital warts between sex partners, 
concordance in sex partners for genotype-specific HPV infection, the rarity of genital HPV 
infection in virgin women, and increased risk of HPV acquisition following new and recent 
sex partners (Winer et al, 2008; Winer et al, 2008b; Burchell et al, 2006). The practice of anal 
intercourse is also associated with HPV detection in the anal canal in men who have sex 
with men and to a lesser degree for women (Dunne et al, 2006; Moscicki et al, 1999). 
Transmission may also occur via other sexual practices, such as oral sex, digital-vaginal sex 
and use of insertive sex toys (Edwards et al, 1998; Sonnex et al, 1999; Gervaz et al, 2003). For 
example, oral sex may explain why husband of women with cervical cancer are at higher 
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risk of upper aerodigestive track cancer (Hemminki et al, 2000). Studies on genital HPV 
infection between women who have sex with women also suggest the possibility of 
transmission between female sex partners (Marrazzo et al 2000). More studies are also 
available on the transmissibility of HPV; the evidence is that HPV is highly transmissible 
(Barnabas et al, 2006; Burchell et al, 2010). For example, Barnabas et al. (2006) estimated the 
per-partner male-to-female transmission probability as much as 60% for HPV-16.  
3.2 Vertical transmission  
Non-sexual routes of transmission are believed to be far less common, but possible. 
Transmission of HPV from mother to child (perinatal infection) was first reported in 1956 
(Hajek, 1956) in a case of juvenile laryngeal papillomatosis (JLP). Confirmation of the 
perinatal transmission of HPV in different mucosa (genital, oral) was subsequently 
supported by several studies although the route of transmission is not well understood 
(Syrjänen et al, 2000). Direct maternal transmission during vaginal delivery or at caesarean 
section following early membrane rupture is possible as well as in utero through semen or 
ascending infection from mother’s genital tract (Syrjänen et al, 2000; Favre et al, 1998). 
Transplancental transmission is also possible since HPV DNA has been detected by PCR in 
amniotic fluid of HPV positive pregnant women. HPV 16 DNA has also been found in cord 
blood cells.  See section on children for an estimate of the probability of transmission of HPV 
at birth.  
3.3 Horizontal transmission and other route 
Horizontal transmission had also been reported; possible routes of infection are the fingers 
and mouth, fomites and skin contact outside sexual contact. For example, transmission from 
the anogenital region to hands is possible via self-inoculation (Hernandez et al, 2008). 
Although possible, this non-sexual route of transmission is also believed to be far less 
common than sexual contact route, especially in adult. Obviously, the horizontal route is 
more important in children (excluding sexually abused children) than the sexual route 
although vertical transmission do occurs. For example, the presence of oral HPV DNA is 
detected in buccal cavities of 19–35% of healthy children aged 6–11 years (Puranen et al, 
1997; Summersgill et al, 2001; Kojima et al, 2003). Blood transmission of HPV as well as 
transmission via breast milk is implausible since HPV infection does not produce viremia 
(Cason et al, 2005). 
4. Epidemiology of HPV infection in adult 
4.1 Anogenital HPV infection in women 
4.1.1 Prevalence, incidence, duration, co-infection and re-infection  
There are many studies that have reported on cervical HPV epidemiology. Studies on the 
prevalence of HPV around the world show that the prevalence of cervical HPV infection 
ranges from 2 to 44%. This wide variation in the prevalence estimates is largely explained by 
the age and the region of the populations studied. Typically, HPV prevalence increases 
rapidly following the onset of sexual activity (highest prevalence occurs among young 
women / adolescent). In fact, cervicovaginal HPV infection is rarely observed among 
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virgins, even among those who engage in sexual activity other than intercourse (Kjaer et al, 
2001). The peak after sexual debut is usually followed by an age-related decline in 
prevalence, and occasionally a second but more modest peak in prevalence among older 
women.(~› 45 years) (Trottier et al, 2006). The prevalence of cervical HPV infection is 
estimated at 5.2%, 8.7%, 12.9%, 14.3% and 25.6% in Europe, Asia, North America, South 
America and Sub-Saharan Africa, respectively (Clifford et al., Lancet 2005,  Burchell et al. 
2006).  HPV-16 is the most common genotype in all regions of the world except in Eastern 
Africa, Japan and Taiwan, where HPV 52 is the most frequent genotype  but overall, the top 
ranked genotypes are HPVs 16, 18, 31, 58, and 52 (de Sanjosé et al, 2007). Coinfection with 
multiple HPV genotypes is also a very common finding of many epidemiologic studies. For 
example, among the cohort of Brazilian women, between 1.9% to 3.2%  were co-infected 
with multiples genotypes at a same visit (concurrently infected) whereas when considering 
cumulatively (period prevalence) during the first year and the first 4 years of follow-up, 
12.3% and 22.3% were infected with multiple genotypes, respectively (Trottier et al, 2006b). 
We also have to take into account that positivity for HPV is typically higher in 
cervicovaginal than in exclusively cervical specimens (Bauer et al; 1991).  
The incidence of cervical HPV infections has also been well studied in many cohorts of young 
or college-aged women. These cohort studies have shown that the cumulative incidence of 
cervical HPV infection exceeded 40% after 3 years among women who were initially HPV 
negative at enrolment (Trottier et al, 2006). These studies also had shown that the cumulative 
incidence is higher for high risk genotypes than for low-risk genotypes. As with prevalence, 
incidence rates of HPV in women tend to decline with age, although second peaks are 
sometimes observed in older women. In fact, over 75% of sexually active women will contract 
HPV in their lifetime and its detection is strongly and consistently associated with the number 
of sexual partners. In most cases, HPV infection is transient or intermittent; only a very small 
proportion of cervical HPV infection will persist and progress toward cervical cancer 
(Schiffman et al, 2003). The median duration of cervical infection for any HPV genotype 
appears to range between 4 and 20 months (Trottier et al, 2006).  
Recent evidence shown that re-infection with HPV (with a different or either a same 
genotype) is a common occurrence (Trottier et al, 2010). Prior infection with HPV does not 
provide women with adequate immunity against subsequent infections. In fact, serum 
antibody levels after natural HPV infection when detectable are low and 40-50% of women 
do not develop measurable antibody response after HPV natural infection (Viscidi et al, 
2004; Nonnenmacher et al, 1995; Park et al, 1998; Heim et al, 2002; Skjeldestad et al, 2008). 
Moreover, it has been shown that an infection with a specific genotype does not decrease the 
probability of being infected by a phylogenetically-related genotype (Thomas et al, 2000). 
Recent studies have shown that re-infection with a same genotype, as well as incident 
infection in older women who had multiple lifetime sexual partners, are associated with 
new sexual partners suggesting that infection in adult women may results not only from 
reactivation (infections acquired at a young age that never completely cleared but become 
undetectable and appeared later in life) but also from new exposure via sexual activity 
(Trottier et al, 2010; Munoz et al, 2004).  
Relatively little is known about the epidemiology of anal HPV infection in women compare 
to cervical infection. However the few studies that reported on anal HPV infection shown 
that it is very common (Goodman et al, 2008; 2010; Shvetsov et al, 2009). When both cervical 
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and anal HPV testing is done, anal HPV is more common than cervical HPV (Williams et al, 
1994; Palefsky et al, 2001). More recently, Goodman et al. (2010) reported that cervical and 
anal HPV infections do occur consecutively and that the risk of one increases the risk of the 
other and vice versa. They also reported on prevalence, incidence and clearance rates of 
genotype-specific anal HPV infection in women. The period prevalence of anal HPV was as 
much as 70% for a follow-up period that averaged 1.3 years (Goodman et al, 2008). The 
incidence of anal HPV infection was 50% through a follow-up period of average duration of 
1.2 years whereas the median duration of anal HPV infection was 150 days (Shvetsov et al, 
2009). In sum, data suggest that women's risk of anal HPV infection is at least as common (if 
not more common) as their risk of cervical HPV infection. 
4.2 Anogenital HPV infection in men 
4.2.1 Prevalence, incidence, duration  
Compared to women, far fewer studies have been conducted among men but evidence 
suggests that the prevalence may even be more important in male. Depending of the 
anatomic sites (specifically the glans, corona, prepuce/foreskin and shaft, with improved 
HPV detection if a scrotal, perianal and/or anal canal sample is also obtained), the 
prevalence of anogenital HPV-DNA positivity among men ranges from 0 to 73% and is 
usually more than 20% (Giuliano et al, 2007; 2008; Dunne et al, 2006; Weaver et al, 2004). 
Also, HR-HPV appears to occur in a higher proportion of male than female infections 
(Giuliano et al, 2008b) and such as for women, penile HPV prevalence typically increases 
with the number of sex partners (Giuliano et al, 2007; Dunne et al, 2006; Weaver et al, 2004). 
Importantly and unlike for women, the available data do not indicate marked differences in 
HPV prevalence across age groups in men (Giuliano et al, 2008c). In fact, after the onset of 
sexual activity, HPV prevalence in men is relatively stable across age group.   
Some cohort studies revealed that anogenital HPV incidence is at least as high among men 
as it is in women, with cumulative incidences ranging from 14 to 62% within 3 to 24 months 
(Dunn et al, 2006; Giuliano et al, 2008, Partridge et al, 2006; 2007). Although far fewer data 
are available for men, infection seems to be of short duration compare to women with a 
median duration of 5.9 months and no evidence for a difference in duration between 
oncogenic and non-oncogenic infections (Giuliano et al, 2008; Kjaer et al, 2005; Lajous et al, 
2005). Only one study has reported on the risk of infection with multiple types in male and 
found that coinfection with multiple HPV genotypes was very common; the cumulative 
incidence of multiple genotypes after 24 months of follow-up of heterosexually active male 
university students 18–20 years was 35.6% (Partridge et al, 2007). There is no available study 
concerning the probability of re-infection with a same or a different genotype in men.  
4.2.2 Special case for men who have sex with men 
Men who have sex with men (MSM) have been observed to have a particularly high 
prevalence of HPV infections (Chin-Hong et al, 2004; Palefsky et al, 1998) and especially 
HIV positive MSM (de Pokomandy et al, 2009).  Cohort studies of HIV-positive MSM 
revealed that the prevalence of anal HPV is more than 95% in these men, with high rates of 
multiple HPV genotype infections and lower genotype-specific HPV clearance rates (de 
Pokomandy et al, 2009; Kiviat et al, 1990; Palefsky et al 2005).  
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4.3 Oral HPV infection in adults 
It is clear that oral mucosa act as a reservoir for HPV. A systematic review (Kreimer et al, 
2010) of studies on oral HPV infection among 4070 healthy and cancer free individuals 
estimated the prevalence of oral HPV infection (any genotypes) of 4.5%. More specifically, 
1.3% had oral HPV-16 and 3.5% had carcinogenic HPV. In this systematic review oral HPV-
16 accounted for 28% of all HPV detected in the oral region and there was no difference in 
the oral prevalence between men and women. Other recent studies had shown nearly the 
same prevalence. A study among 1,688 healthy men aged 18 to 74 (median = 31 years) in 
United States, Mexico, and Brazil shown that the prevalence of oral HPV infection was 4% 
(Kreimer et al, 2011) whereas the study of Matsushita et al (2011) estimate oral HPV 
prevalence at 6.1%. Genotypes mostly detected included HPVs -16 and -18 and the tonsil 
appears to be the site with the highest prevalence.  
4.4 Conjunctival HPV infection in adult 
It is also clear that conjunctival mucosa act as a reservoir for HPV. LR-HPV such as HPVs -6 
and -11 as well as HR-HPV, such as genotypes 16 and 33 are associated with the occurrence 
of conjunctival papilloma (Sjö et al, 2007). Ateenyi-Agaba et al. (2010) have tested 
conjunctival biopsy samples from healthy individuals to estimate the prevalence of HPV. 
The prevalence of mucosal HPVs was 3.5%, the prevalence of cutaneous HPVs was 10.5% 
whereas the prevalence multiple-genotype infections was present in 13.3% (Ateenyi-Agaba 
et al, 2010). It is possible that conjunctival tissues are more likely to be infected with 
cutaneous genotypes because of horizontal transmission.  
5. Epidemiology of HPV infection in infant and children  
The few studies available on genital and oral HPV infection in children have shown clear 
evidence of HR-HPV infections in healthy children (Kojima et al, 2003; Summersgill et al, 
2001; Smith et al, 2007; Rice et al, 2000; Syrjänen et al, 2000). Sexual abuse and vertical and 
horizontal transmission may explain the positivity in children. This chapter focuses on the 
evidence about the epidemiology of HPV in children and not on the possible route of 
transmission since it is impossible to distinguish between both routes based simply on the 
clinical/epidemiological data. What is well known is that both routes (sexual and non-
sexual) are possible. For example, perinatal HPV transmission has been unequivocally 
identified as a possible cause for the rare disease called Juvenile-Onset Recurrent 
Respiratory papillomatosis (JORRP) (Wiatrak et al, 2004). 
Confirmation of the perinatal transmission of HPV in different mucosa (genital, oral) is 
supported by several studies. These studies have reported widely varying probability of 
infection in newborns, with estimates from the first couple of days of life ranging from 4 to 
79% among infants born to mothers testing positive for HPV DNA during pregnancy (Table 3).  
Although perinatal transmission may be observed in baby born by caesarean, it is usually 
admitted that caesarean decreases the risk of perinatal infection. For example, a significantly 
higher rate of HPV 16/18 infection was found at birth when infants were delivered vaginally 
than when infants were delivered by cesarean (51.4% versus 27.3%) (Tseng et al, 1998).  A 
systematic review (Medeiros  et al, 2005) reported a higher risk of HPV infection after vaginal 
delivery than after cesarean section (RR: 1.8; 95%CI: 1.3-2.4). The risk of transmission has also 
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been identified as increasing with the rupture of membranes; the longer time rupture of 
membranes occurred before delivery, higher risk of transmission (Tenti et al, 1999).  
 
Study, year; 
country 
Genotype of HPV 
Sample 
(number of 
HPV+ pregnant 
mother) 
 
Transmission rate 
at birth 
Follow-up 
Tseng et al, 
1998;   
Taiwan 
16, 18 
68 
 
40 % (buccal and 
genital) 
delivery 
Puranen et 
al, 1997;  
Finland 
6, 11, 16, 18 
42 
 
 
79% 
(nasopharyngeal) 
delivery 
Chatterjee et 
al, 1998; 
India 
6, 11, 16, 18 12 42% (buccal) delivery 
Tenti et al, 
1999; 
Italy 
 
6, 11, 16, 18, 31, 
33, 35, 39, 51, 54, 
56, 58, 59, 66, 68, 
69, 70, 83, 84 
37 
30% 
(oropharyngeal) 
18 mths 
Bandyopadh
yay et al, 
2003; 
India 
6, 11, 16, 18, 31, 33 38 18% (buccal) 12 mths 
Smith et al, 
2004;  
United States 
6, 11, 16, 18, 31, 
33, 53, 66 
172 4% (buccal, genital) 6 mths 
Rintala et al, 
2005; 
Finland 
 
16, 18, 31, 33, 35, 
39, 45, 51, 52, 54, 
56, 58 
Include 77 
newborns 
(15% and 9% of 
newborns had 
genital or oral HPV 
infection, at birth, 
respectively 
2 yrs 
Rombaldi et 
al, 2009; 
Brazil 
6/11, 16, 18, 31, 
33, 42, 52, 58 
49 
20% (buccal, 
axillary and 
inguinal regions) 
1 yr 
Castellsagué 
et al, 2009; 
Spain 
6, 11, 16, 18, 31, 
33, 39 
66 
19.7% (mouth and 
anogenital 
exfoliated cells) 
2 yrs 
Table 3: Cohort studies on HPV perinatal transmission 
Only a few studies have analysed the probability of persistence among babies born to HPV-
infected mothers such as Rombaldi et al (2009) and Watts et al. (1998) who have reported a 
very low proportion of persistent infection in infants (reported 0% in a 1 and 3-year follow-
up study, respectively) whereas some reported very high proportions ranging from 27 to 
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56% (Fredericks et al, 1993; Kaye et al, 1994; Pakarian et al, 1994; Cason et al, 1995, 2005; 
Syrjänen et al, 2000). These studies have shown that perinatally acquired HPV can persist for 
at least 2 years and that HPV is mostly prevalent during the first year of infancy reaching a 
peak at 6 months of age. 
Anogenital warts may also be transmitted perinatally (Jayasingue et al, 2006; Sinal et al, 
2005; Marcoux et al, 2006; Sinclair et al, 2005; Jones et al, 2007). Boyd (1990) has shown that 
at least 20% of anogenital warts occur because of perinatal transmission. Although the 
incubation period for children is not known, a period of several months typically elapses 
between viral infection at delivery and clinical manifestations (Monk et al, 2007). A review 
of studies of the HPV genotype distribution in anogenital warts in children has shown that 
75% are caused by genotypes 6 and 11, 11% by HPV-2, 6% by HPV-16 and -18 and 3% by 
HPV-27 and -57 (Syrjänen et al, 2000; Sinal et al, 2005; Marcoux et al, 2006; Aguilera-
Barrantes et al, 2007). Since the 1990s, the incidence of anogenital warts has dramatically 
increased in adults as well as in children (Syrjänen et al, 2000). To summarize, it is clear that 
perinatal transmission of HPV occurred although the frequency at which it occurred and 
persist remains controversial. 
It is also clear that infants and children might acquire oral and genital HPV infection 
postnatally from a variety of sources such as direct transmission (person-to-person or auto-
inoculation), indirect transmission (via contaminated objects) and sexual abuse (Syrjänen et 
al, 2000). For example, in their longitudinal study of the prevalence of HR-HPV in oral and 
genital mucosa of infants during their first 3 years of life, Rintala et al. (2005b) found that 
42% of infants (negative at birth) had acquired an oral HR-HPV infection (from which 10% 
had persistent infection) and 36% had acquired a genital HR-HPV infection (from which 
1.5% had persisted). Some cross-sectional studies have estimated the prevalence of HPV 
among children of different age-groups. The estimates of prevalence of HPV (detected by 
PCR) in oral swabs from children aged 0-13 years range from 32 to 52% (Rice et al, 2000; 
Syrjänen et al, 2000). In their review of studies that analyzed PCR-detected HR-HPV during 
infancy and childhood, Cason et al. (2005) reported HPV prevalences ranging from 9 to 55%. 
However, oral HPV infection is likely to decrease with age. The study of Marais et al. (2006) 
had compared oral HPV prevalence among children, adolescent and adult. They found that 
oral HPV infection was highest in children (7.9%), followed by adolescents (5.1%), and 
lowest in normal adults (3.5%).  Mamas et al. (2011) also shown the presence of HPV in the 
lower respiratory tract of healthy children; 8% of bronchoalveolar lavage of children (2-12 
years old) they tested were positive for HPV. Finally, there are no available studies on the 
prevalence of conjunctival HPV in children although papilloma represents 7-10% of 
conjunctival benign tumors in childhood where HPV-6 and -11 are the major genotypes 
responsible for conjunctival lesions (Okan et al, 2010).   
There are some studies that reported cases of squamous cell carcinoma (SCC) involving the 
larynx/lung in childhood which transformed from the recurrent respiratory papillomatosis 
with HPV (Lin et al, 2010; Katsenos et al, 2011) but cancers associated with HPV in 
childhood are not frequent. However, although rare, cancers related to HPV are increasing 
in recent years in children and this increasing correlates with increased prevalence of HPV 
in the community (Chow et al, 2007). Moreover and importantly, they are no longitudinal 
studies available to clarify whether children exposed to HPV (oral, anogenital or 
conjunctival) are at risk of developing carcinoma in adulthood. A better understanding the 
natural history of HPV infection in children is clearly needed. 
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6. Conclusion 
Anogenital HPV infection is very common with high prevalences found in both females and 
males. Typically, anogenital HPV prevalence increases rapidly in adolescents/young adults 
following sexual debut, and the highest prevalence occurs among this population (Kjaer et 
al, 2001). The probability of finding a cervicovaginal HPV infections in women decrease 
after that according to age with a possible peak at older age whereas it is relatively stable 
according to age for men. The predominant route of HPV transmission is through sexual 
contact although vertical and horizontal transmissions are possible. Most sexually-active 
individuals are likely to be exposed to anogenital HPV infection during their lifetimes and 
most infections will be cleared spontaneously within a year. A small fraction of people will 
have persistent infection with HR-HPVs, which is unequivocally established as a necessary 
cause of cervical cancer and is likely to be responsible for a substantial proportion of other 
anogenital neoplasms and non negligible number of head and neck cancers. Persistent 
infection result in substantial morbidity and invoke high costs associated with the treatment 
of clinically relevant lesions. Oral and conjunctival infections may also exist in adults 
although the epidemiology of these infections has been less studied. Children are also 
exposed to HPV as anogenital and oral samples of healthy children have often been found 
positive. The incidence of HPV-associated diseases, such as squamous cell carcinomas, has 
increased in children in recent years which may be, in part, related to an increase in HPV 
prevalence (Syrjänen et al, 2000; Chow et al, 2007). HPV vaccination, one of the most 
remarkable discoveries of the past decade, is currently implanted all around the world and 
is expected to prevent a substantial proportion of cervical and other HPV-related cancers in 
the future. 
7. References 
Aguilera-Barrantes I, Magro C, Nuovo GJ. Verruca vulgaris of the vulva in children and 
adults: a nonvenereal type of vulvar wart. Am J Surg Pathol 2007; 31(4):529-35. 
Ateenyi-Agaba C, Franceschi S, Wabwire-Mangen F, Arslan A, Othieno E, Binta-Kahwa J, 
van Doorn LJ, Kleter B, Quint W, Weiderpass E. Human papillomavirus infection 
and squamous cell carcinoma of the conjunctiva. Br J Cancer 2010; 102(2):262-7. 
Armstrong LR, Preston EJ, Reichert M, Phillips DL, Nisenbaum R, Todd NW, Jacobs IN, 
Inglis AF, Manning SC, Reeves WC. Incidence and prevalence of recurrent 
respiratory papillomatosis among children in Atlanta and Seattle. Clin Infect Dis. 
2000; 31(1):107-9. 
Bandyopadhyay S, Sen S, Majumdar L, Chatterjee R. Human papillomavirus infection 
among Indian mothers and their infants. Asian Pac J Cancer Prev 2003; 4(3):179-84. 
Barnabas R, Laukkanen P, Koskela P, Kontula O, Lehtinen M, Garnett G: Epidemiologyof 
HPV 16 and cervical cancer in Finland and the potential impact of vaccination: 
mathematical modelling analyses. PLoS Med 2006; 3:e138. 
Bauer HM, Ting Y, Greer CE, Chambers JC, Tashiro CJ, Chimera J, Reingold A, Manos MM. 
Genital human papillomavirus infection in female university students as 
determined by a PCR-based method. JAMA 1991; 265:472-7. 
Boyd AS. Condylomata acuminata in the pediatric population. Am J Dis Child 1990; 
144(7):817-24. 
www.intechopen.com
 
Epidemiology of Mucosal Human Papillomavirus (HPV) Infections Among Adult and Children 
 
13 
Burchell AN, Winer RL, de Sanjosé S, Franco EL: Epidemiology and transmission dynamics 
of genital human papillomavirus infection. Vaccine 2006; 24:S52–S61. 
Burchell AN, Tellier PP, Hanley J, Coutlée F, Franco EL. Human papillomavirus infections 
among couples in new sexual relationships. Epidemiology 2010; 21(1):31-7. 
Cason J, Kaye J, Pakarian F, Raju KS, Best JM. HPV-16 transmission. Lancet 1995; 345: 197-8. 
Cason J, Mant CA. High-risk mucosal human papillomavirus infections during infancy & 
childhood. J Clin Virol 2005; 32 Suppl 1:S52-8. 
Castellsagué X, Drudis T, Cañadas MP, Goncé A, Ros R, Pérez JM, Quintana MJ, Muñoz J, 
Albero G, de Sanjosé S, Bosch FX. Human Papillomavirus (HPV) infection in 
pregnant women and mother-to-child transmission of genital HPV genotypes: a 
prospective study in Spain. BMC Infect Dis 2009; 9:74. 
Chaterjee R, Mukhopadhyay D, Murmu N, Mitra PK. Correlation between human 
papillomavirus DNA detection in maternal cervical smears and buccal swabs of 
infants. Indian J Exp Biol 1998; 36(2):199-202. 
Chin-Hong PV, Vittinghoff E, Cranston RD, Buchbinder S, Cohen D, Colfax G, Da Costa M, 
Darragh T, Hess E, Judson F, Koblin B, Madison M, Palefsky JM. Age-specific 
prevalence of anal human papillomavirus infection in HIV-negative sexually active 
men who have sex with men: the EXPLORE study. J Infect Dis 2004; 190:2070–76. 
Chow CW, Tabrizi SN, Tiedemann K, Waters KD. Squamous cell carcinomas in children and 
young adults: a new wave of a very rare tumor? J Pediatr Surg. 2007; 42(12):2035-9. 
Clifford GM, Gallus S, Herrero R, Muñoz N, Snijders PJ, Vaccarella S, Anh PT, Ferreccio C, 
Hieu NT, Matos E, Molano M, Rajkumar R, Ronco G, de Sanjosé S, Shin HR, 
Sukvirach S, Thomas JO, Tunsakul S, Meijer CJ, Franceschi S. Worldwide 
distribution of human papillomavirus genotypes in cytologically normal women in 
the International Agency for Research on Cancer HPV prevalence surveys: a pooled 
analysis. Lancet 2005; 366(9490):991-8. 
de Pokomandy A, Rouleau D, Ghattas G, Vézina S, Côté P, Macleod J, Allaire G, Franco EL, 
Coutlée F. Prevalence, clearance, and incidence of anal human papillomavirus 
infection in HIV-infected men. J Infect Dis 2009;199:965-73.  
de Sanjosé S, Diaz M, Castellsagué X, Clifford G, Bruni L, Muñoz N, Bosch FX. Worldwide 
prevalence and genotype distribution of cervical human papillomavirus DNA in 
women with normal cytology: a meta-analysis. Lancet Infect Dis 2007; 7(7):453-9. 
de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classification of 
papillomaviruses. Virology 2004; 324:17–27. 
Dunne EF, Nielson CM, Stone KM, Markowitz LE, Giuliano AR. Prevalence of HPV 
infection among men: a systematic review of the literature. J Infect Dis 2006; 
194:1044–57. 
Edwards S, Carne C. Oral sex and the transmission of viral STIs. Sex Transm Infect 1998; 
74:6–10.  
Favre M, Majewski S, De Jesus N, Malejczyk M, Orth G, Jablonska S. A possible vertical 
transmission of human papillomavirus genotypes associated with 
epidermodysplasia verruciformis. J Invest Dermatol 1998; 111(2):333-6. 
Fredericks BD, Balkin A, Daniel HW, Schonrock J, Ward B, Frazer IH. Transmission of 
human papillomavirus from mother to child. Aust NZ.J Obstet Gynaecol 1993; 
33:30–2. 
Gervaz P, Allal AS, Villiger P, Buhler L, Morel P. Squamous cell carcinoma of the anus: 
another sexually transmitted disease. Swiss Med Wkly 2003; 133:353–9. 
www.intechopen.com
Human Papillomavirus and Related Diseases 
– From Bench to Bedside – Research Aspects 
 
14
(c) Giuliano AR, Lazcano-Ponce E, Villa LL, Flores R, Salmeron J, Lee JH, Papenfuss MR, 
Abrahamsen M, Jolles E, Nielson CM, Baggio ML, Silva R, Quiterio M. HPV 
prevalence and type-distribution among men residing in Brazil, Mexico and the US. 
Cancer Epidemiol Biomarkers Prev 2008; 17: 2036–43. 
( b) Giuliano AR, Tortolero-Luna G, Ferrer E, Burchell AN, de Sanjosé S, Kjaer SK, Muñoz. 
N, Schiffman M, Bosch FX. Epidemiology of human papillomavirus infection in 
men, cancers other than cervical and benign conditions. Vaccine 2008; 26(S10):K17–
K28. 
Giuliano AR, Lu B, Nielson CM, Flores R, Papenfuss MR, Lee JH, Abrahamsen M, Harris 
RB. Age-specific prevalence, incidence, and duration of human papillomavirus 
infections in a cohort of 290 US men. J Infect Dis 2008; 198: 827–35. 
Giuliano AR, Nielson CM, Flores R, Dunne EF, Abrahamsen M, Papenfuss MR, Markowitz 
LE, Smith D, Harris RB. The optimal anatomic sites for sampling heterosexual men 
for human papillomavirus (HPV) detection: the HPV Detection in Men Study. J 
Infect Dis 2007; 196: 1146–52. 
Goodman MT, Shvetsov YB, McDuffie K, Wilkens LR, Zhu X, Thompson PJ, Ning L, Killeen 
J, Kamemoto L, Hernandez BY. Sequential acquisition of human papillomavirus 
(HPV) infection of the anus and cervix: the Hawaii HPV Cohort Study. J Infect Dis 
2010; 201:1331-9. 
Goodman MT, Shvetsov YB, McDuffie K, Wilkens LR, Zhu X, Ning L, Killeen J, Kamemoto 
L, Hernandez BY. Acquisition of anal human papillomavirus (HPV) infection in 
women: the Hawaii HPV Cohort study. J Infect Dis 2008; 197:957-66. 
Hajek EF. Contribution to the etiology of laryngeal papilloma in children. J Laryngol Otol. 
1956; 70(3):166-8. 
Heim K, Widschwendter A, Pirschner G, Wieland U, Awerkiew S, Christensen ND, Bergant 
A, Marth C, Höpfl R. Antibodies to human papillomavirus 16 L1 virus-like 
particles as an independent prognostic marker in cervical cancer. Am J Obstet 
Gynecol 2002; 186(4):705-11. 
Hemminki K, Dong C. Cancer in Husbands of Cervical Cancer Patients. Epidemiology 2000; 
11(3): 347-9. 
Hernandez BY, Wilkens LR, Zhu X, Thompson P, McDuffie K, Shvetsov YB, Kamemoto LE, 
Killeen J, Ning L, Goodman MT. Transmission of human papillomavirus in 
heterosexual couples. Emerg Infect Dis 2008; 14: 888–94. 
International Agency for Research on Cancer (IARC). Monographs on the evaluation of 
carcinogenic risks to humans. Human papillomaviruses, vol. 90. Lyon, France; 
2007. 
International Agency for Research on Cancer (IARC). Monographs on the Evaluation of 
Carcinogenic Risks to Humans, vol. 100B, Lyon, France; 2011.  
Jayasinghe Y, Garland SM. Genital warts in children: what do they mean? Arch Dis Child 
2006; 91(8):696-700. 
Jones V, Smith SJ, Omar HA. Nonsexual transmission of anogenital warts in children: a 
retrospective analysis. ScientificWorld Journal 2007; 7:1896-9. 
Kashima HK, Shah F, Lyles A, Glackin R, Muhammad N, Turner L, Van Zandt S, Whitt S, 
Shah K. A comparison of risk factors in juvenile-onset and adult-onset recurrent 
respiratory papillomatosis. Laryngoscope 1992; 102(1):9-13. 
www.intechopen.com
 
Epidemiology of Mucosal Human Papillomavirus (HPV) Infections Among Adult and Children 
 
15 
Katsenos S, Becker HD. Recurrent respiratory papillomatosis: a rare chronic disease, difficult 
to treat, with potential to lung cancer transformation: apropos of two cases and a 
brief literature review. Case Rep Oncol. 2011; 4(1):162-71. 
Kaye JN, Cason J, Pakarian FB, Jewers RJ, Kell B, Bible J, Raju KS, Best JM. Viral load as a 
determinant for transmission of human papillomavirus type 16 from mother to 
child. J Med Virol 1994; 44(4):415-21. 
Kiviat N, Rompalo A, Bowden R, Galloway D, Holmes KK, Corey L, Roberts PL, Stamm 
WE. Anal human papillomavirus infection among human immunodeficiency virus-
seropositive and -seronegative men. J Infect Dis 1990; 162:358-61. 
Kjaer SK, Chackerian B, van den Brule AJ, Svare EI, Paull G, Walbomers JM, Schiller JT, 
Bock JE, Sherman ME, Lowy DR, Meijer CL. High-risk human papillomavirus is 
sexually transmitted: evidence from a follow up study of virgins starting sexual 
activity (intercourse). Cancer Epidemiol Biomarkers Prev 2001; 10: 101–6. 
Kjaer SK, Munk C, Winther JF, Jorgensen HO, Meijer CJLM, van den Brule AJC. Acquisition 
and persistence of human papillomavirus infection in younger men: a prospective 
follow-up study among Danish soldiers. Cancer Epidemiol Biomarkers Prev 2005; 
14: 1528–33.  
Kojima A, Maeda H, Kurahashi N, Sakagami G, Kubo K, Yoshimoto H, Kameyama Y. 
Human papillomaviruses in the normal oral cavity of children in Japan. Oral Oncol 
2003; 39(8):821–8. 
Kreimer AR, Bhatia RK, Messeguer AL, González P, Herrero R, Giuliano AR. Oral human 
papillomavirus in healthy individuals: a systematic review of the literature. Sex 
Transm Dis 2010; 37(6):386-91. 
Kreimer AR, Villa A, Nyitray AG, Abrahamsen M, Papenfuss M, Smith D, Hildesheim A, 
Villa LL, Lazcano-Ponce E, Giuliano AR. The epidemiology of oral HPV infection 
among a multinational sample of healthy men. Cancer Epidemiol Biomarkers Prev 
2011; 20(1):172-82. 
Lajous M, Mueller N, Cruz-Valdez A, Aguilar LV, Franceschi S, Hernandez-Avila M, 
Lazcano-Ponce E. Determinants of prevalence, acquisition, and persistence of 
human papillomavirus in health Mexican military men. Cancer Epidemiol 
Biomarkers Prev 2005; 14: 1710–16. 
Lin HW, Richmon JD, Emerick KS, de Venecia RK, Zeitels SM, Faquin WC, Lin DT. 
Malignant transformation of a highly aggressive human papillomavirus type 11-
associated recurrent respiratory papillomatosis. Am J Otolaryngol 2010; 31:291–6. 
Mammas IN, Zaravinos A, Sourvinos G, Spandidos DA. Detection of human papillomavirus 
in bronchoalveolar lavage samples in immunocompetent children. Pediatr Infect 
Dis J. 2011; 30(5):384-6. 
Marais DJ, Sampson C, Jeftha A, Dhaya D, Passmore JA, Denny L, Rybicki EP, Van Der Walt 
E, Stephen LX, Williamson AL. More men than women make mucosal IgA 
antibodies to Human papillomavirus type 16 (HPV-16) and HPV-18: a study of oral 
HPV and oral HPV antibodies in a normal healthy population. BMC Infect Dis 
2006; 6:95. 
Marcoux D, Nadeau K, McCuaig C, Powell J, Oligny LL. Pediatric anogenital warts: a 7-year 
review of children referred to a tertiary-care hospital in Montreal, Canada. Pediatr 
Dermatol 2006; 23(3):199-207. 
Marrazzo JM, Stine K, Koutsky LA. Genital human papillomavirus infection in women who 
have sex with women: a review. Am J Obstet Gynecol 2000; 183: 770–4. 
www.intechopen.com
Human Papillomavirus and Related Diseases 
– From Bench to Bedside – Research Aspects 
 
16
Matsushita K, Sasagawa T, Miyashita M, Ishizaki A, Morishita A, Hosaka N, Saikawa K, 
Hoshina S, Bi X, Ichimura H. Oral and cervical human papillomavirus infection 
among female sex workers in Japan. Jpn J Infect Dis 2011; 64(1):34-9. 
Medeiros LR, Ethur AB, Hilgert JB, Zanini RR, Berwanger O, Bozzetti MC, Mylius LC. 
Vertical transmission of the human papillomavirus: a systematic quantitative 
review. Cad Saude Publica. 2005;21(4):1006-15.  
Monk BJ, Tewari KS. The spectrum and clinical sequelae of human papillomavirus infection. 
Gynecol Oncol 2007; 107(2 Suppl 1):S6-13. 
Moscicki AB, Hills NK, Shiboski S, Darragh TM, Jay N, Powell K, Hanson E, Miller SB, 
Farhat S, Palefsky J. Risk factors for abnormal anal cytology in young heterosexual 
women. Cancer Epidemiol Biomarkers Prev 1999; 8: 173–8. 
Muñoz N, Méndez F, Posso H, Molano M, van den Brule AJ, Ronderos M, Meijer C, Muñoz 
A; Instituto Nacional de Cancerologia HPV Study Group. Incidence, duration, and 
determinants of cervical human papillomavirus infection in a cohort of Colombian 
women with normal cytological results. J Infect Dis 2004; 190:2077–87. 
Nonnenmacher B, Hubbert NL, Kirnbauer R, Shah KV, Muñoz N, Bosch FX, de Sanjosé S, 
Viscidi R, Lowy DR, Schiller JT. Serologic response to human papillomavirus type 
16 (HPV-16) virus-like particles in HPV-16 DNA-positive invasive cervical cancer 
and cervical intraepithelial neoplasia grade III patients and controls from Colombia 
and Spain. J Infect Dis 1995; 172(1):19-24. 
Okan G, Ayan I, Karslioğlu S, Altiok E, Yenmiş G, Vural G. Conjunctival papilloma caused 
by human papillomavirus type 11 treated with systemic interferon in a five-year-
old boy. Turk J Pediatr 2010; 52(1):97-100. 
Pakarian F, Kaye J, Cason J, Kell B, Jewers R, Derias NW, Raju KS, Best JM. Cancer 
associated human papillomaviruses: perinatal transmission and persistence. Br J 
Obstet Gynaecol 1994; 101(6):514-7. 
Palefsky JM, Holly EA, Efirdc JT, Da Costa M, Jay N, Berry JM, Darragh TM. Anal 
intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-
positive men who have sex with men. AIDS 2005; 19:1407-14. 
Palefsky JM, Holly EA, Ralston ML, Da Costa M, Greenblatt RM. Prevalence and risk factors 
for anal human papillomavirus infection in human immunodeficiency virus (HIV)-
positive and high-risk HIV-negative women. J Infect Dis 2001; 183:383-91 
Palefsky JM, Holly EA, Ralston ML, Jay N. Prevalence and risk factors for human 
papillomavirus infection of the anal canal in human immunodeficiency virus 
(HIV)-positive and HIV-negative homosexual men. J Infect Dis 1998; 177: 361–7. 
Park J, Sun D, Genest DR, Trivijitsilp P, Suh I, Crum CP. Coexistence of low and high grade 
squamous intraepithelial lesions of the cervix: morphologic progression or multiple 
papillomaviruses? Gynecol Oncol 1998; 70(3):386-91. 
Partridge J, Koutsky L: Genital human papillomavirus infection in men. Lancet Infect Dis 
2006; 6: 21–31. 
Partridge JM, Hughes JP, Feng Q, Winer RL, Weaver BA, Xi LF, Stern ME, Lee SK, O’Reilly 
SF, Hawes SE, Kiviat NB, Koutsky LA. Genital human papillomavirus infection in 
men: incidence and risk factors in a cohort of university students. J Infect Dis 2007; 
196: 1128–36. 
Puranen MH, Yliskoski MH, Saarikoski SV, Syrjänen KJ, Syrjänen SM. Exposure of an infant 
to cervical human papillomavirus infection of the mother is common. Am J Obstet 
Gynecol 1997; 176(5):1039–45. 
www.intechopen.com
 
Epidemiology of Mucosal Human Papillomavirus (HPV) Infections Among Adult and Children 
 
17 
Rice PS, Mant C, Cason J, Bible JM, Muir P, Kell B, Best JM. High prevalence of human 
papillomavirus type 16 infection among children. J Med Virol 2000; 61(1):70-5. 
Rintala MA, Grénman SE, Puranen MH, Isolauri E, Ekblad U, Kero PO, Syrjänen SM. 
Transmission of high-risk human papillomavirus (HPV) between parents and 
infant: a prospective study of HPV in families in Finland. J Clin Microbiol 2005; 
43(1):376-81. 
(b) Rintala MA, Grénman SE, Järvenkylä ME, Syrjänen KJ, Syrjänen SM. High-risk types of 
human papillomavirus (HPV) DNA in oral and genital mucosa of infants during 
their first 3 years of life: experience from the Finnish HPV Family Study. Clin Infect 
Dis 2005; 15;41(12):1728-33. 
Rombaldi RL, Serafini EP, Mandelli J, Zimmermann E, Losquiavo KP. Perinatal transmission 
of human papilomavirus DNA. Virol J. 2009 Jun 21;6:83. 
Schiffman M, Castle PE. Human papillomavirus: epidemiology and public health. Arch 
Pathol Lab Med 2003; 127: 930–4. 
Shvetsov YB, Hernandez BY, McDuffie K, Wilkens LR, Zhu X, Ning L, Killeen J, Kamemoto 
L, Goodman MT. Duration and clearance of anal human papillomavirus (HPV) 
infection among women: the Hawaii HPV cohort study. Clin Infect Dis 2009; 
48:536-46. 
Sinal SH, Woods CR. Human papillomavirus infections of the genital and respiratory tracts 
in young children. Semin Pediatr Infect Dis 2005; 16(4):306-16. 
Sinclair KA, Woods CR, Kirse DJ, Sinal SH. Anogenital and respiratory tract human 
papillomavirus infections among children: age, gender, and potential transmission 
through sexual abuse. Pediatrics 2005; 116(4):815-25. 
Sjö NC, von Buchwald C, Cassonnet P, Norrild B, Prause JU, Vinding T, Heegaard S. 
Human papillomavirus in normal conjunctival tissue and in conjunctival 
papilloma: types and frequencies in a large series. Br J Ophthalmol 2007; 91: 1014–
15. 
Skjeldestad FE, Mehta V, Sings HL, Øvreness T, Turpin J, Su L, Boerckel P, Roberts C, Bryan 
J, Jansen KU, Esser MT, Liaw KL. Seroprevalence and genital DNA prevalence of 
HPV types 6, 11, 16 and 18 in a cohort of young Norwegian women: study design 
and cohort characteristics. Acta Obstet Gynecol Scand 2008; 87(1):81-8. 
Smith EM, Swarnavel S, Ritchie JM, Wang D, Haugen TH, Turek LP. Prevalence of human 
papillomavirus in the oral cavity/oropharynx in a large population of children and 
adolescents. Pediatr Infect Dis J 2007; 26(9):836-40. 
Smith EM, Ritchie JM, Yankowitz J, Swarnavel S, Wang D, Haugen TH, Turek LP. Human 
papillomavirus prevalence and types in newborns and parents: concordance and 
modes of transmission. Sex Transm Dis. 2004;31(1):57-62. 
Sonnex C, Strauss S, Gray JJ. Detection of human papillomavirus DNA on the fingers of 
patients with genital warts. Sex Transm Infect 1999; 75: 317–9. 
Summersgill KF, Smith EM, Levy BT, Allen JM, Haugen TH, Turek LP. Human 
papillomavirus in the oral cavities of children and adolescents. Oral Surg Oral Med 
Oral Pathol Oral Radiol Endod 2001; 91(1):62-9. 
Syrjänen S, Puranen M. Human papillomavirus infections in children: the potential role of 
maternal transmission. Crit Rev Oral Biol Med 2000; 11(2):259-74. 
Tenti P, Zappatore R, Migliora P, Spinillo A, Belloni C, Carnevali L. Perinatal transmission 
of human papillomavirus from gravidas with latent infections. Obstet Gynecol 
1999; 93(4):475-9. 
www.intechopen.com
Human Papillomavirus and Related Diseases 
– From Bench to Bedside – Research Aspects 
 
18
Thomas KK, Hughes JP, Kuypers JM, Kiviat NB, Lee SK, Adam DE, Koutsky LA. 
Concurrent and sequential acquisition of different genital human papillomavirus 
types. J Infect Dis 2000; 182: 1097–102. 
Trottier H, Franco EL: The epidemiology of genital human papillomavirus infection. Vaccine 
2006; 24(suppl 1):S1–S15. 
(b) Trottier H, Mahmud S, Costa MC, Sobrinho JP, Duarte-Franco E, Rohan TE, Ferenczy A, 
Villa LL, Franco EL. Human papillomavirus infections with multiple types and risk 
of cervical neoplasia. Cancer Epidemiol Biomarkers Prev 2006; 15(7):1274-80. 
Trottier H, Burchell AN. Epidemiology of mucosal human papillomavirus infection and 
associated diseases. Public Health Genomics 2009; 12(5-6):291-307. 
Trottier H, Ferreira S, Thomann P, Costa MC, Sobrinho JS, Prado JC, Rohan TE, Villa LL, 
Franco EL. Human papillomavirus infection and reinfection in adult women: the 
role of sexual activity and natural immunity. Cancer Res 2010; 70(21):8569-77. 
Tseng CJ, Liang CC, Soong YK, Pao CC. Perinatal transmission of human papillomavirus in 
infants: Relationship between infection rate and mode of delivery. Obstet. Gynecol 
1998; 91:92–6. 
Viscidi RP, Schiffman M, Hildesheim A, Herrero R, Castle PE, Bratti MC, Rodriguez AC, 
Sherman ME, Wang S, Clayman B, Burk RD. Seroreactivity to human 
papillomavirus (HPV) types 16, 18, or 31 and risk of subsequent HPV infection: 
results from a population-based study in Costa Rica. Cancer Epidemiol Biomarkers 
Prev 2004; 13(2):324-7. 
Watts DH, Koutsky LA, Holmes KK, Goldman D, Kuypers J, Kiviat NB, Galloway DA. Low 
risk of perinatal transmission of human papillomavirus: results from a prospective 
cohort study. Am J Obstet Gynecol 1998; 178(2):365-73. 
Weaver BA, Feng Q, Holmes KK, Kiviat N, Lee SK, Meyer C, Stern M, Koutsky LA. 
Evaluation of genital sites and sampling techniques for detection of human 
papillomavirus DNA in men. J Infect Dis 2004; 189: 677–85. 
Wiatrak BJ, Wiatrak DW, Broker TR, Lewis L. Recurrent respiratory papillomatosis: a 
longitudinal study comparing severity associated with human papilloma viral 
types 6 and 11 and other risk factors in a large pediatric population. Laryngoscope 
2004; 114(11 Pt 2 Suppl 104):1-23. 
Williams AB, Darragh TM, Vranizan K, Ochia C, Moss AR, Palefsky JM. Anal and cervical 
human papillomavirus infection and risk of anal and cervical epithelial 
abnormalities in human immunodeficiency virus-infected women. Obstet Gynecol 
1994; 83:205-11. 
Winer RL, Koutsky LA: Genital human papillomaviruses; in Holmes KK, et al (eds): 
Sexually Transmitted Diseases, ed 4. New York, McGraw Hill Medical 2008, pp 
489–508. 
b) Winer RL, Feng Q, Hughes JP, O’Reilly S, Kiviat SB, Koutsky LA. Risk of female human 
papillomavirus acquisition associated with first male sex partner. J Infect Dis 2008; 
197: 279–82. 
www.intechopen.com
Human Papillomavirus and Related Diseases - From Bench to
Bedside - Research aspects
Edited by Dr. Davy Vanden Broeck
ISBN 978-953-307-855-7
Hard cover, 406 pages
Publisher InTech
Published online 25, January, 2012
Published in print edition January, 2012
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
Cervical cancer is the second most prevalent cancer among women worldwide, and infection with Human
Papilloma Virus (HPV) has been identified as the causal agent for this condition. The natural history of cervical
cancer is characterized by slow disease progression, rendering the condition, in essence, preventable and
even treatable when diagnosed in early stages. Pap smear and the recently introduced prophylactic vaccines
are the most prominent prevention options, but despite the availability of these primary and secondary
screening tools, the global burden of disease is unfortunately still very high. This book will focus on
epidemiological and fundamental research aspects in the area of HPV, and it will update those working in this
fast-progressing field with the latest information.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
Helen Trottier (2012). Epidemiology of Mucosal Human Papillomavirus (HPV) Infections Among Adult and
Children, Human Papillomavirus and Related Diseases - From Bench to Bedside - Research aspects, Dr. Davy
Vanden Broeck (Ed.), ISBN: 978-953-307-855-7, InTech, Available from:
http://www.intechopen.com/books/human-papillomavirus-and-related-diseases-from-bench-to-bedside-
research-aspects/epidemiology-of-mucosal-human-papillomavirus-hpv-infections-among-adult-and-children
© 2012 The Author(s). Licensee IntechOpen. This is an open access article
distributed under the terms of the Creative Commons Attribution 3.0
License, which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
